IPHA Forex News

Innate Pharma Says FDA Places Partial Clinical Hold On Lacutamab IND; Stock Down 10%

Innate Pharma SA (IPHA) announced Thursday that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the lacutamab IND. This has led to a pause in new patient enrollment to the Company's ongoing lacutamab trials IPH4102-201 (Phase 2 TELLOMAK) and 102 (Phase 1b PTCL).

RTTNews | 639 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.17788	GBPUSD	1.36532	AUDUSD	0.65507
USDJPY	144.479	USDCAD	1.36033	USDCHF	0.79342

Advertisement

IPHA Forex News

Innate Pharma Says FDA Places Partial Clinical Hold On Lacutamab IND; Stock Down 10%